Evidence map›Paper›PMID 34762146›Full record

ArticleJournal of neurology2022

White matter connectivity networks predict levodopa-induced dyskinesia in Parkinson's disease.

Jin Ho Jung, Yae Ji Kim, Seok Jong Chung, Han Soo Yoo, Yang Hyun Lee, Kyoungwon Baik, Seong Ho Jeong, Young Gun Lee, Hye Sun Lee, Byoung Seok Ye and 3 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Jin Ho Jung *Department of Neurology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea.
Yae Ji Kim *Program of Brain and Cognitive Engineering, Korea Advanced Institute of Science and Technology, Daejeon, South Korea.
Seok Jong ChungDepartment of Neurology, Yonsei University College of Medicine, Seoul, South Korea.
Han Soo YooDepartment of Neurology, Yonsei University College of Medicine, Seoul, South Korea.
Yang Hyun LeeDepartment of Neurology, Yonsei University College of Medicine, Seoul, South Korea.
Kyoungwon BaikDepartment of Neurology, Yonsei University College of Medicine, Seoul, South Korea.
Seong Ho JeongDepartment of Neurology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, South Korea.
Young Gun LeeDepartment of Neurology, Yonsei University College of Medicine, Seoul, South Korea.
Hye Sun LeeBiostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, South Korea.
Byoung Seok YeDepartment of Neurology, Yonsei University College of Medicine, Seoul, South Korea.
Young H SohnDepartment of Neurology, Yonsei University College of Medicine, Seoul, South Korea.
Yong JeongProgram of Brain and Cognitive Engineering, Korea Advanced Institute of Science and Technology, Daejeon, South Korea. yong@kaist.ac.kr.
Phil Hyu LeeDepartment of Neurology, Yonsei University College of Medicine, Seoul, South Korea. phlee@yuhs.ac.ORCID http://orcid.org/0000-0001-9931-8462
Yonsei University · KRKorea Advanced Institute of Science and Technology · KRInje University Busan Paik Hospital · KRInje University Sanggye Paik Hospital · KR

Funding

National Research Foundation of Korea 2019R1A2C2085462
6 · The paper itself

Abstract

backgroundAlthough levodopa-induced dyskinesia-relevant white matter change has been evaluated, it is uncertain whether these changes may reflect the underlying predisposing conditions leading to the development of levodopa-induced dyskinesia.

objectiveTo elucidate the role of white matter connectivity networks in the development of levodopa-induced dyskinesia in drug-naïve Parkinson's disease.

methodsWe recruited 30 patients who developed levodopa-induced dyskinesia within 5 years from MRI acquisition (vulnerable-group), 47 patients who had not developed levodopa-induced dyskinesia within 5 years (resistant-group), and 28 controls. We performed comparative analyses of whole-brain white matter integrity and connectivity using tract-based spatial and network- and degree-based statistics. We evaluated the predictability of levodopa-induced dyskinesia development and relationship with its latency, using the average connectivity strength as a predictor in Cox- and linear-regression, respectively.

resultsMean-diffusivity was lower mainly at the left frontal region in the vulnerable-group compared to the resistant-group. Network-based statistics identified a subnetwork consisting of the bilateral fronto-striato-pallido-thalamic and lateral parietal regions (subnetwork A) and degree-based statistics identified four subnetworks (hub-subnetwork) consisting of edges centered on the left superior frontal gyrus, left putamen, left insular, or left precentral gyrus, where the vulnerable-group had stronger connectivity compared to the resistant-group. Stronger connectivity within the subnetwork A and hub-subnetwork centered on the left superior frontal gyrus was a predictor of levodopa-induced dyskinesia development independent of known risk factors and had an inverse relationship with its latency.

conclusionsOur data suggest that white matter connectivity subnetworks within corticostriatal regions play a pivotal role in the development of levodopa-induced dyskinesia.

Indexed as

Dyskinesia, Drug-InducedParkinson DiseaseWhite MatterAntiparkinson AgentsHumansLevodopaAntiparkinson AgentsLevodopaDegree-based statisticsLevodopa-induced dyskinesiaNetwork-based statisticsParkinson’s diseaseWhite matter connectivity

Identifiers

PMID34762146
OpenAlexW3211581530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.